Literature DB >> 22072243

Comparison of magnetic resonance imaging findings in non-ST-segment elevation versus ST-segment elevation myocardial infarction patients undergoing early invasive intervention.

Jianqiang Xu1, Young Bin Song, Joo-Yong Hahn, Sung-A Chang, Sang-Chol Lee, Yeon Hyeon Choe, Seung-Hyuk Choi, Jin-Ho Choi, Sang Hoon Lee, Jae K Oh, Hyeon-Cheol Gwon.   

Abstract

To define causes and pathological mechanisms underlying differences in clinical outcomes, we compared the findings of contrast-enhanced magnetic resonance imaging (CE-MRI) between ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI). In 168 patients undergoing early invasive intervention for STEMI (n = 113) and NSTEMI (n = 55), CE-MRI was performed a median of 6 days after the index event. Infarct size was measured on delayed-enhancement imaging, and area at risk (AAR) was quantified on T2-weighted images. The median infarct size was significantly smaller in the NSTEMI group than in the STEMI group (10.7% [5.6-18.1] vs. 19.2% [10.3-30.7], P < 0.001). Although there was a trend toward a greater myocardial salvage index ([AAR - infarct size] × 100/AAR) in the NSTEMI group compared to the STEMI group (48.2 [30.4-66.8] vs. 40.5 [24.8-53.5], P = 0.056), myocardial salvage index was similar between the groups in patients with anterior infarction (39.6 [20.0-54.9] vs. 35.5 [23.2-53.4], P = 0.96). The NSTEMI group also had a significantly lower extent of microvascular obstruction and a smaller number of segments with >75% of infarct transmurality relative to the STEMI group (0% [0-0.6] vs. 0.9% [0-2.3], P < 0.001 and 3.0 ± 2.3 vs. 4.6 ± 2.9, P = 0.001, respectively). Myocardial hemorrhage was detected less frequently in the NSTEMI group than the STEMI group (22.6% vs. 43.8%, P = 0.029). In the multivariate analysis, baseline Thrombolysis In Myocardial Infarction flow grade 3 and hemorrhagic infarction were closely associated with ST-segment elevation (OR 0.32, 95% CI 0.13-0.81, P = 0.017; OR 5.66, 95% CI 1.77-18.12, P = 0.003, respectively). In conclusion, in vivo pathophysiological differences revealed by CE-MRI assessment include more favorable infarct size, AAR, myocardial salvage and reperfusion injury in patients with NSTEMI compared to those with STEMI undergoing early invasive intervention.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072243     DOI: 10.1007/s10554-011-9975-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  29 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Upstream high-dose tirofiban does not reduce myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging pilot study.

Authors:  Young Bin Song; Joo-Yong Hahn; Hyeon-Cheol Gwon; Jun Hyung Kim; Sang Yeub Lee; Yeon Hyeon Choe; Seung-Hyuk Choi; Jin-Ho Choi; Sang Hoon Lee
Journal:  Clin Cardiol       Date:  2009-06       Impact factor: 2.882

3.  Myocardial salvage by CMR correlates with LV remodeling and early ST-segment resolution in acute myocardial infarction.

Authors:  Pier Giorgio Masci; Javier Ganame; Elisabetta Strata; Walter Desmet; Giovanni Donato Aquaro; Steven Dymarkowski; Valentina Valenti; Stefan Janssens; Massimo Lombardi; Frans Van de Werf; Antonio L'Abbate; Jan Bogaert
Journal:  JACC Cardiovasc Imaging       Date:  2010-01

4.  Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers.

Authors:  Suzanne de Waha; Steffen Desch; Ingo Eitel; Georg Fuernau; Johannes Zachrau; Anja Leuschner; Matthias Gutberlet; Gerhard Schuler; Holger Thiele
Journal:  Eur Heart J       Date:  2010-07-30       Impact factor: 29.983

5.  Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk.

Authors:  Adam N Mather; Timothy A Fairbairn; Stephen G Ball; John P Greenwood; Sven Plein
Journal:  Heart       Date:  2010-11-04       Impact factor: 5.994

6.  Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).

Authors:  David A Cox; Gregg W Stone; Cindy L Grines; Thomas Stuckey; Peter J Zimetbaum; James E Tcheng; Mark Turco; Eulogio Garcia; Giulio Guagliumi; Robert S Iwaoka; Roxana Mehran; William W O'Neill; Alexandra J Lansky; John J Griffin
Journal:  Am J Cardiol       Date:  2006-06-09       Impact factor: 2.778

7.  Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study.

Authors:  E Wu; J T Ortiz; P Tejedor; D C Lee; C Bucciarelli-Ducci; P Kansal; J C Carr; T A Holly; D Lloyd-Jones; F J Klocke; R O Bonow
Journal:  Heart       Date:  2007-12-10       Impact factor: 5.994

8.  Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.

Authors:  A W van 't Hof; A Liem; H Suryapranata; J C Hoorntje; M J de Boer; F Zijlstra
Journal:  Circulation       Date:  1998-06-16       Impact factor: 29.690

9.  Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry).

Authors:  J Dawn Abbott; Hanna N Ahmed; Helen A Vlachos; Faith Selzer; David O Williams
Journal:  Am J Cardiol       Date:  2007-06-04       Impact factor: 2.778

10.  Cardiovascular magnetic resonance of scar and ischemia burden early after acute ST elevation and non-ST elevation myocardial infarction.

Authors:  Sven Plein; John F Younger; Patrick Sparrow; John P Ridgway; Stephen G Ball; John P Greenwood
Journal:  J Cardiovasc Magn Reson       Date:  2008-10-25       Impact factor: 5.364

View more
  7 in total

1.  Angiographic validation of magnetic resonance assessment of myocardium at risk in non-ST-elevation myocardial infarction.

Authors:  Dominik Buckert; Manuela Mariyadas; Thomas Walcher; Volker Rasche; Jochen Wöhrle; Wolfgang Rottbauer; Peter Bernhardt
Journal:  Int J Cardiovasc Imaging       Date:  2013-04-02       Impact factor: 2.357

2.  Microvascular obstruction in patients with non-ST-elevation myocardial infarction: a contrast-enhanced cardiac magnetic resonance study.

Authors:  Elena Guerra; Martin Hadamitzky; Gjin Ndrepepa; Corinna Bauer; Tareq Ibrahim; Ilka Ott; Karl-Ludwig Laugwitz; Heribert Schunkert; Adnan Kastrati
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-30       Impact factor: 2.357

Review 3.  Imaging the myocardial microcirculation post-myocardial infarction.

Authors:  Steven K White; Derek J Hausenloy; James C Moon
Journal:  Curr Heart Fail Rep       Date:  2012-12

4.  Evaluating the optimal timing of revascularisation in patients with transient ST-segment elevation myocardial infarction: rationale and design of the TRANSIENT Trial.

Authors:  Jorrit Lemkes; Robin Nijveldt; Aernout M Beek; Paul Knaapen; Alexander Hirsch; Joost Meijers; Cor P Allaart; Albert van Rossum; Niels van Royen
Journal:  J Cardiovasc Transl Res       Date:  2014-05-30       Impact factor: 4.132

5.  Effects of high-dose atorvastatin pretreatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a cardiac magnetic resonance study.

Authors:  Eun Kyoung Kim; Joo-Yong Hahn; Young Bin Song; Sung-A Chang; Jin-Ho Choi; Seung-Hyuk Choi; Sang-Chol Lee; Yeon Hyeon Choe; Sang Hoon Lee; Hyeon-Cheol Gwon
Journal:  J Korean Med Sci       Date:  2015-03-19       Impact factor: 2.153

6.  Metabolomic Profiling in Acute ST-Segment-Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia-Reperfusion Injury.

Authors:  Matthias Kohlhauer; Sam Dawkins; Ana S H Costa; Regent Lee; Timothy Young; Victoria R Pell; Robin P Choudhury; Adrian P Banning; Rajesh K Kharbanda; Kourosh Saeb-Parsy; Michael P Murphy; Christian Frezza; Thomas Krieg; Keith M Channon
Journal:  J Am Heart Assoc       Date:  2018-04-06       Impact factor: 5.501

7.  Thrombus Aspiration in ThrOmbus containing culpRiT lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI): study protocol for a randomized controlled trial.

Authors:  Suzanne de Waha; Ingo Eitel; Steffen Desch; Bruno Scheller; Michael Böhm; Bernward Lauer; Meinrad Gawaz; Tobias Geisler; Oliver Gunkel; Leonhard Bruch; Norbert Klein; Dietrich Pfeiffer; Gerhard Schuler; Uwe Zeymer; Holger Thiele
Journal:  Trials       Date:  2013-04-25       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.